Literature DB >> 4479578

Absorption, distribution and excretion of alprenolol in man, dog and rat.

N O Bodin, K O Borg, R Johansson, H Obianwu, R Svensson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4479578     DOI： 10.1111/j.1600-0773.1974.tb00745.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics of mepindolol sulphate in animals.

Authors:  W Krause; G Kühne; U Täuber
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.

Authors:  D W Costain; A R Green
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

Review 4.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

5.  Tissue distribution of exaprolol in rat.

Authors:  V Faberová; T Trnovec; M Zemánek; S Bezek; M Durisová; O Tomcíková
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jan-Mar       Impact factor: 2.441

6.  Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.

Authors:  E A Taylor; D Jefferson; J D Carroll; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

7.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.

Authors:  P H Hinderling; O Schmidlin; J K Seydel
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

8.  Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).

Authors:  G Goldaniga; L Montesanti; E Pianezzola; G Valzelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.